Boardroom Alpha
Start trial
8-K primary document
BWXT · Current Report (Form 8-K) · Filed February 20, 2026

Bwx Technologies Inc — 8-K exhibit

tm266839d1_ex99-1.htm
Bwx Technologies Inc on Boardroom Alpha

 

Exhibit 99.1

 

 

 

BWXT Appoints Dan Jablonsky to Board of Directors

 

(MELBOURNE, Fla. – Feb. 20, 2026) BWX Technologies, Inc. (NYSE: BWXT) announced today that Dan Jablonsky has been appointed to its board of directors effective March 2, 2026. He will also serve on the board’s audit and finance committee.

 

Jablonsky most recently served as chief executive officer and chairman of Ursa Major, a leading provider of advanced propulsion systems for space and defense applications. He has held senior leadership roles in the aerospace and defense industry for more than a decade. Prior to Ursa Major, Jablonsky served as president and chief executive officer of Maxar Technologies, where he led the NYSE-listed company through a comprehensive turnaround and growth strategy, culminating in a $6.4 billion take-private acquisition by Advent International. Prior to that, he was general counsel and then president of DigitalGlobe. Jablonsky began his career as a surface warfare officer and nuclear engineer in the U.S. Navy before transitioning to law practice.

 

“We are excited to welcome Dan to BWXT’s board,” said Jan Bertsch, chair of BWXT’s board of directors. “His deep expertise in space technologies, combined with his perspective as an active CEO leading a high-growth aerospace company, will provide valuable insight as BWXT accelerates its growth in the space and defense sectors.”

 

Jablonsky holds a bachelor’s degree in mechanical engineering from the United States Naval Academy, graduated from the Navy Nuclear Power School and earned a Juris Doctor from the University of Washington School of Law.

 


About BWXT

 

At BWX Technologies, Inc. (NYSE: BWXT), we are People Strong, Innovation Driven. A U.S.-based company with approximately 10,000 employees, BWXT is a Fortune 1000 and Defense News Top 100 manufacturing and engineering innovator that provides safe and effective nuclear solutions for global security, clean energy, nuclear medicine, space exploration and environmental restoration. BWXT owns and operates 17 manufacturing facilities globally, and its 14 strategic partnerships support the U.S. and Canadian governments at more than two dozen additional locations.

 

For more information, visit www.bwxt.com. Follow us on LinkedIn, X, Facebook and Instagram.

 

###

 

Media Contact

John Dobken

Senior Manager, Media & Public Relations

202.428.6913

jcdobken@bwxt.com

 

Investor Contact

Chase Jacobson

Vice President, Investor Relations

980.365.4300 

investors@bwxt.com

 

 

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer